Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Martens

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Superconductor Science & Technology|November 25, 2017
Conceptual designs of conduction cooled MgB2 magnets for 1.5 and 3.0T full body MRI systemsTanvir Baig, Abdullah Al Amin, Robert J Deissler, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 16, 2016
Pretransplantation Exercise and Hematopoietic Cell Transplantation Survival: A Secondary Analysis of Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0902)John R Wingard, William A Wood, Michael Martens, et al.
JTO Clinical and Research Reports|November 18, 2024
High-Grade Pneumonitis Events in Patients With Unresectable, Locally Advanced NSCLC Treated With Definitive Chemoradiation Followed by Adjuvant DurvalumabCiani Ellison, Michael Martens, Juliana Alvarez Argote, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 28, 2016
Patient-Reported Outcomes and Socioeconomic Status as Predictors of Clinical Outcomes after Hematopoietic Stem Cell Transplantation: A Study from the Blood and Marrow Transplant Clinical Trials Network 0902 TrialJennifer M Knight, Karen L Syrjala, Navneet S Majhail, et al.
Blood|November 19, 2019
Randomized multicenter trial of sirolimus vs prednisone as initial therapy for standard-risk acute GVHD: the BMT CTN 1501 trialJoseph Pidala, Mehdi Hamadani, Peter Dawson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 30, 2016
Allogeneic Transplantation for Relapsed Waldenström Macroglobulinemia and Lymphoplasmacytic LymphomaRobert F Cornell, Veronika Bachanova, Anita D'Souza, et al.
Transplantation and Cellular Therapy|June 27, 2026
Infections within 100 days of idecabtagene vicleucel and impact on survival for relapsed/refractory multiple myeloma: A CIBMTR AnalysisKitsada Wudhikarn, Lohith Gowda, Qiran Ye, et al.
Blood|July 5, 2017
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United StatesLori Muffly, Marcelo C Pasquini, Michael Martens, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Superconductor Science & Technology|November 25, 2017
Conceptual designs of conduction cooled MgB2 magnets for 1.5 and 3.0T full body MRI systemsTanvir Baig, Abdullah Al Amin, Robert J Deissler, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 16, 2016
Pretransplantation Exercise and Hematopoietic Cell Transplantation Survival: A Secondary Analysis of Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0902)John R Wingard, William A Wood, Michael Martens, et al.
JTO Clinical and Research Reports|November 18, 2024
High-Grade Pneumonitis Events in Patients With Unresectable, Locally Advanced NSCLC Treated With Definitive Chemoradiation Followed by Adjuvant DurvalumabCiani Ellison, Michael Martens, Juliana Alvarez Argote, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 28, 2016
Patient-Reported Outcomes and Socioeconomic Status as Predictors of Clinical Outcomes after Hematopoietic Stem Cell Transplantation: A Study from the Blood and Marrow Transplant Clinical Trials Network 0902 TrialJennifer M Knight, Karen L Syrjala, Navneet S Majhail, et al.
Blood|November 19, 2019
Randomized multicenter trial of sirolimus vs prednisone as initial therapy for standard-risk acute GVHD: the BMT CTN 1501 trialJoseph Pidala, Mehdi Hamadani, Peter Dawson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 30, 2016
Allogeneic Transplantation for Relapsed Waldenström Macroglobulinemia and Lymphoplasmacytic LymphomaRobert F Cornell, Veronika Bachanova, Anita D'Souza, et al.
Transplantation and Cellular Therapy|June 27, 2026
Infections within 100 days of idecabtagene vicleucel and impact on survival for relapsed/refractory multiple myeloma: A CIBMTR AnalysisKitsada Wudhikarn, Lohith Gowda, Qiran Ye, et al.
Blood|July 5, 2017
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United StatesLori Muffly, Marcelo C Pasquini, Michael Martens, et al.
Pageof 2